Nosisbio
1 known investors
Nosis develops a platform for receptor-targeted delivery of RNA therapeutics to specific cell types, addressing a key bottleneck in RNA drug development. The company aims to reduce the cost and timeline of bringing new RNA medicines to market.
AI & Machine LearningBiotechDeep TechMedical Devices